# Gsk (gsk.fr): agent-readiness 76/100, grade B

> Rank 28 of 1000 on Qomvia (rubric v2.3.0). Last scanned 2026-09-28T18:50:45.906Z. Page: https://qomvia.com/site/gsk-fr  JSON: https://qomvia.com/api/score/gsk-fr

## Summary

{
  "known": true,
  "confidence": "high",
  "summary": "GSK (GlaxoSmithKline) is a major global pharmaceutical and healthcare company. It focuses on the research, development, manufacture, and marketing of innovative medicines, vaccines, and consumer healthcare products.",
  "offerings": [
    "Prescription medicines",
    "Vaccines",
    "Over-the-counter medicines",
    "Oral health products",
    "Nutritional products"
  ],
  "audience": "Patients, healthcare professionals, researchers, investors, and the general public interested in healthcare solutions.",
  "geography": "Global, with significant operations and presence in numerous countries, including France.",
  "strengths": [
    "One of the largest pharmaceutical companies globally",
    "Strong focus on research and development of new treatments",
    "Extensive portfolio of vaccines for various diseases",
    "Well-established consumer healthcare brands",
    "Long history and reputation in the pharmaceutical industry"
  ],
  "unknowns": [
    "Specific market share for each product category in France",
    "Detailed financial performance metrics for the gsk.fr domain's direct impact",
    "Specific employee numbers solely for GSK France's digital operations",
    "User engagement metrics for the gsk.fr website",
    "Full details of their local CSR initiatives beyond general statements"
  ],
  "alternatives": [
    "gsk.com",
    "gsk.co.uk",
    "gsk.de"
  ],
  "business": "Global pharmaceutical and healthcare company developing, manufacturing, and marketing medicines, vaccines, and consumer health products for patients and consumers worldwide.",
  "competitors": [
    "pfizer.com",
    "novartis.com",
    "sanofi.com",
    "astrazeneca.com",
    "merck.com",
    "roche.com",
    "jnj.com"
  ]
}

## Score by group
- Machine access: 24/24
- Content legibility: 21/26
- Discovery surface: 15/20
- Identity & policy: 3/12
- Agent-facing performance: 8/8
- Agent protocols: 5/10
Failing checks:
- [blocker] No discoverable sitemap
- [blocker] The site does not say who it is
- [improvement] No stated policy for automated access
- [improvement] No Content Signals
- [improvement] Nothing says when the content changed

## Add-on packs
- E-commerce & product feeds: 36/100 (not part of the public score)

## AI mentions and rivals
- pfizer.com: not measured
- novartis.com: not measured
- sanofi.com: not measured
- merck.com: not measured
- roche.com: not measured

## FAQ
Q: Is Gsk readable by AI agents?
A: Gsk (gsk.fr) scores 76 out of 100 for agent readiness, grade B, measured 2 days ago, on 28.09.2026. 1 of 3 agent classes we test can use the site, and 2 checks currently block agents outright.

Q: What stops agents from using gsk.fr?
A: The heaviest problems are: No discoverable sitemap; The site does not say who it is; No stated policy for automated access; No Content Signals; Nothing says when the content changed. Each one is scored from a public HTTP response, and the fix for each is listed in the signed-in report.

Q: How is the Gsk agent-readiness score calculated?
A: Qomvia fetches public pages of gsk.fr as an AI agent would and runs the core checks every site gets across 6 groups: Machine access, Content legibility, Discovery surface, Identity & policy, Agent-facing performance, Agent protocols. Checks are weighted by how much an agent loses when they fail, and the score is expressed out of 100. E-commerce & product feeds checks are scored separately (36/100) and do not affect the public score or rank.

Q: How often is this score updated?
A: Public scores are re-checked when the site is re-scanned; tracked domains are re-scanned weekly and their owners are alerted when a check regresses. This page shows the scan from 2 days ago, on 28.09.2026.

## Related
- Leaderboard: https://qomvia.com/leaderboard
- Score another site: https://qomvia.com/